Biotech

All Articles

8 months after a $213M fundraise, gene publisher Tome makes cuts

.After raising $213 thousand in 2023-- one of the year's most extensive exclusive biotech shots-- To...

BioMarin constructs exec team along with biotech veterinarians-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings...

Biopharma Q2 VC struck highest level because '22, while M&ampA slowed down

.Equity capital financing into biopharma cheered $9.2 billion throughout 215 sell the 2nd fourth of ...

Bicara, Zenas find IPOs to drive late-phase properties toward market

.Bicara Rehabs and also Zenas Biopharma have actually offered fresh inspiration to the IPO market al...

Genentech to close cancer cells immunology research study department

.Genentech is going to close its cancer immunology study division, and also device mind as well as p...

Kezar falls strong lump however to prove its well worth in phase 1 test

.Kezar Lifestyle Sciences is actually falling its dim period 1 solid tumor medicine as the biotech g...

Acelyrin loses izokibep, lets go 3rd of personnel

.In spite of izokibep preserving its own newfound winning streak in the center, Acelyrin is no more ...

Rivus' stage 2 obesity-related cardiac arrest test hits endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its own fat-busting, muscle-sparing medicine ...

Ovid stops preclinical work, IV program after soticlestat fall short

.Ovid Therapy already uncovered final month that it was trimming its headcount as the provider brows...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Seaport

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston ma Seaport, enhancing its...